Expression of IFN-γ upon triggering of activating Ly49d NK receptors in vitro and in vivo: Costimulation with IL-12 or IL-18 overrides inhibitory receptors

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1763-1769

  Ortaldo, John R ^a   Young, Howard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; PROTEIN; PROTEIN LY49D; STAT4 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; MOLECULAR MECHANICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

EID: 0037441999     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1763     Document Type: Article

References (32)

1. Ryan, J. C., and W. E. Seaman. 1997. Divergent functions of lectin-like receptors on NK cells. Immunol. Rev. 155:79.
2. Mason, L. H., P. Gosselin, S. K. Anderson, W. E. Fogler, J. R. Ortaldo, and D. W. McVicar. 1997. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J. Immunol. 159:4187.
3. + NK cells promote hematopoietic growth in H-2d strain mice. J. Immunol. 155:2911.
4. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77.
5. Nakamura, M. C., E. C. Niemi, M. J. Fisher, L. D. Shultz, W. E. Seaman, and J. C. Ryan. 1997. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. Med. 185:673.
6. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.
7. Olcese, L., A. Cambiaggi, G. Semenzato, C. Bottino, A. Moretta, and E. Vivier. 1997. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158:5083.
8. Mason, L. H., S. K. Anderson, W. M. Yokoyama, H. R. Smith, R. Winkler-Pickett, and J. R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184:2119.
9. Gosselin, P., L. H. Mason, J. Willette-Brown, J. R. Ortaldo, D. W. McVicar, and S. K. Anderson. 1999. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J. Leukocyte Biol. 66:165.
10. Mason, L. H., J. Willette-Brown, S. K. Anderson, P. Gosselin, E. W. Shores. P. E. Love, J. R. Ortaldo, and D. W. McVicar. 1998. Cutting edge: characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J. Immunol. 160:4148.
11. Smith, K. A., J. Wu, A. B. H. Bakker, J. H. Phillips, and L. L. Lanier. 1998. Ly49D and Ly49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161:7.
12. George, T. C., L. H. Mason, J. R. Ortaldo, V. Kumar, and M. Bennett. 1999. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J. Immunol. 162:2035.
13. Nakamura, M. C., P. A. Linnemeyer, E. C. Niemi, L. H. Mason, J. R. Ortaldo, J. C. Ryan, and W. E. Seaman. 1999. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J. Exp. Med. 189:493.
14. Ortaldo, J. R., R. Winkler-Pickett, and G. Wiegand. 2000. Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors. J. Leukocyte Biol. 68:748.
15. Ortaldo, J. R., R. Winkler-Pickett, J. Willette-Brown, R. L. Wange, S. K. Anderson, G. J. Palumbo, L. H. Mason, and D. W. McVicar. 1999. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J. Immunol. 163:5269.
16. Fogler, W. E., K. Volker, K. L. McCormick, M. Watanabe, J. R. Ortaldo, and R. H. Wiltrout. 1996. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707.
17. Ortaldo, J. R., A. T. Mason, R. T. Winkler-Pickett, A. Raziuddin, W. J. Murphy, and L. H. Mason. 1999. Ly-49 receptor expression and functional analysis in multiple mouse strains. J. Leukocyte Biol. 66:512.
18. Ortaldo, J. R., E. W. Bere, D. Hodge, and H. A. Young. 2001. Activating Ly-49 NK receptors: central role in cytokine and chemokine production. J. Immunol. 166:4994.
19. Uzel, G., D. M. Frucht, T. A. Fleisher, and S. M. Holland. 2001. Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin. Immunol. 100:270.
20. + cells. J. Immunol. 160:1158.
21. Siders, W. M., P. W. Wright, J. A. Hixon, W. G. Alvord, T. C. Back, R. H. Wiltrout. and R. G. Fenton. 1998. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. J. Immunol. 160:5465.
22. Wigginton, J. M., E. Gruys, L. Geiselhart, J. Subleski, K. L. Komschlies, J. W. Park, T. A. Wiltrout, K. Nagashima, T. C. Back, and R. H. Wiltrout. 2001. IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of [L-12/pulse IL-2 therapy. J. Clin. Invest. 108:51.
23. Wigginton, J. M., J. K. Lee, T. A. Wiltrout, W. G. Alvord, J. A. Hixon, J. Subleski, T. C. Back, and R. H. Wiltrout. 2002. Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-γ and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2. Immunol. 169:4467.
24. Colquhoun, S. D., J. S. Economou, H. Shau, and S. H. Golub, 1993. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues. J. Surg. Res 55:486.
25. Stotter, H. and M. T. Lotze, 1991. Human lymphokine-activated killer cell activity: role of IL-2, IL-4, and IL-7. Arch. Surg. 126:1525.
26. Idris, A. H., H. R. Smith, L. H. Mason, J. R. Ortaldo, A. A, Scalzo, and W. M. Yokoyama. 1999. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. USA 96:6330.
27. Mason, L. H. 2000. Recognition of CHO cells by inhibitory and activating Ly-49 receptors. J. Leukocyte Biol. 68:583.
28. Nakahira, M., H. J, Ahn, W. R. Park, P. Gao, M. Tomura, C. S. Park, T. Hamaoka, T. Ohta, M. Kurimoto, and H. Fujiwara. 2002. Synergy of IL-12 and IL-18 for IFN-γ gene expression: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J. Immunol. 168:1146.
29. McVicar, D. W., L. S. Taylor, P. Gosselin, J. Willette-Brown, A. Mikhael, R. L. Geahlen, M. C. Nakamura, P. A. Linnemeyer, W. E. Seaman, S. K. Anderson, et al. 1998, DAP12 mediated signal transduction in NK cells: a dominant role for the Syk protein tyrosine kinase. J. Biol. Chem. 273:32934.
30. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M., Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194:29.
31. Pien, G. C., and C. A. Biron. 2000. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. J. Immunol. 164:994.
32. Dokun, A, O., S. Kim, H. R. Smith, H. S. Kang, D. T. Chu, and W. M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:951.